This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prats, G.
Right arrow Articles by Navarro, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prats, G.
Right arrow Articles by Navarro, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2000, p. 1140-1145, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Antibiotic Resistance Trends in Enteropathogenic Bacteria Isolated in 1985-1987 and 1995-1998 in Barcelona

Guillermo Prats,* Beatriz Mirelis, Teresa Llovet, Carmen Muñoz, Elisenda Miró, and Ferran Navarro

Departament de Microbiologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma 08025 Barcelona, Spain

Received 18 October 1999/Returned for modification 23 December 1999/Accepted 18 January 2000

Trends in resistance to antimicrobial agents used for therapy have been evaluated with 3,797 enteropathogenic bacteria, Campylobacter, Salmonella, Shigella, and Yersinia, between 1985-1987 and 1995-1998. The greater increase in the rate of resistance was observed in Campylobacter jejuni for quinolones (from 1 to 82%) and tetracycline (from 23 to 72%) and in gastroenteric salmonellae for ampicillin (from 8 to 44%), chloramphenicol (from 1.7 to 26%), and trimethoprim-sulfamethoxazole and nalidixic acid (from less than 0.5 to 11%). Multidrug resistance was detected in several Salmonella serotypes. In the 1995-1998 period, 76% of Shigella strains were resistant to trimethoprim-sulfamethoxazole, 43% were resistant to ampicillin, and 39% were resistant to chloramphenicol. Seventy-two percent of Yersinia enterocolitica O3 strains were resistant to streptomycin, 45% were resistant to sulfonamides, 28% were resistant to trimethoprim-sulfamethoxazole, and 20% were resistant to chloramphenicol.

* Corresponding author. Mailing address: Departament de Microbiologia, Hospital de la Santa Creu i Sant Pau, Av. Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain. Phone: 34 93 2919071. Fax: 34 93 2919070. E-mail: 2175{at}hsp.santpau.es.

Antimicrobial Agents and Chemotherapy, May 2000, p. 1140-1145, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Quinn, T., Bolla, J.-M., Pages, J.-M., Fanning, S. (2007). Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?. J Antimicrob Chemother 59: 1230-1236 [Abstract] [Full Text]  
  • Wardak, S., Szych, J., Zasada, A. A., Gierczynski, R. (2007). Antibiotic Resistance of Campylobacter jejuni and Campylobacter coli Clinical Isolates from Poland. Antimicrob. Agents Chemother. 51: 1123-1125 [Abstract] [Full Text]  
  • Nguyen, T. V., Le, P. V., Le, C. H., Weintraub, A. (2005). Antibiotic Resistance in Diarrheagenic Escherichia coli and Shigella Strains Isolated from Children in Hanoi, Vietnam. Antimicrob. Agents Chemother. 49: 816-819 [Abstract] [Full Text]  
  • Marimon, J. M., Gomariz, M., Zigorraga, C., Cilla, G., Perez-Trallero, E. (2004). Increasing Prevalence of Quinolone Resistance in Human Nontyphoid Salmonella enterica Isolates Obtained in Spain from 1981 to 2003. Antimicrob. Agents Chemother. 48: 3789-3793 [Abstract] [Full Text]  
  • Gorman, R., Adley, C. C. (2004). Characterization of Salmonella enterica Serotype Typhimurium Isolates from Human, Food, and Animal Sources in the Republic of Ireland. J. Clin. Microbiol. 42: 2314-2316 [Abstract] [Full Text]  
  • Capilla, S., Goni, P., Rubio, M. C., Castillo, J., Millan, L., Cerda, P., Sahagun, J., Pitart, C., Beltran, A., Gomez-Lus, R. (2003). Epidemiological Study of Resistance to Nalidixic Acid and Other Antibiotics in Clinical Yersinia enterocolitica O:3 Isolates. J. Clin. Microbiol. 41: 4876-4878 [Abstract] [Full Text]  
  • Wagner, J., Jabbusch, M., Eisenblatter, M., Hahn, H., Wendt, C., Ignatius, R. (2003). Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline. Antimicrob. Agents Chemother. 47: 2358-2361 [Abstract] [Full Text]  
  • Ferro, V. A., Bradbury, F., Cameron, P., Shakir, E., Rahman, S. R., Stimson, W. H. (2003). In Vitro Susceptibilities of Shigella flexneri and Streptococcus pyogenes to Inner Gel of Aloe barbadensis Miller. Antimicrob. Agents Chemother. 47: 1137-1139 [Abstract] [Full Text]  
  • Aarestrup, F. M., Wiuff, C., Molbak, K., Threlfall, E. J. (2003). Is It Time To Change Fluoroquinolone Breakpoints for Salmonella spp.?. Antimicrob. Agents Chemother. 47: 827-829 [Full Text]  
  • Gomi, H., Jiang, Z.-D., Adachi, J. A., Ashley, D., Lowe, B., Verenkar, M. P., Steffen, R., DuPont, H. L. (2001). In Vitro Antimicrobial Susceptibility Testing of Bacterial Enteropathogens Causing Traveler's Diarrhea in Four Geographic Regions. Antimicrob. Agents Chemother. 45: 212-216 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»